From the American College of Nuclear Medicine: PDF OnlyThe American College of Nuclear Medicine Guidance on Operating Procedures for a Nuclear Medicine Facility During COVID-19 PandemicTulchinsky, Mark MD, FACNM, FSNMMI1; Osmany, Saabry MD, FACNM, FAMS2,3Author Information 1Section of Nuclear Medicine, Department of Radiology, Milton S. Hershey Medical Center, Penn State Health, Hershey, PA 2Osmany Pte Ltd, Singapore 3RadLink PET and Cardiac Imaging Centre, Singapore Endorsed by the Board of Directors of the American College of Nuclear Medicine Received for publication April 20, 2020; revision accepted April 28, 2020. Reprint requests and correspondence: Mark Tulchinsky, MD, FACNM, FSNMMI, Milton S. Hershey Medical Center, M.C. H066, 500 University Drive, Hershey, PA 17033, Phone: 717-514-3428; Fax: 620-628-2705; E-mail: firstname.lastname@example.org This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. Clinical Nuclear Medicine: May 1, 2020 - Volume Publish Ahead of Print - Issue - doi: 10.1097/RLU.0000000000003146 Free PAP Metrics Abstract The novel coronavirus 2 pandemic is causing widespread disruption in everyday life necessitating urgent and radical adaptations in operating procedures at Nuclear Medicine facilities. The potential for causing severe illness, COVID-19, calls for strict observance of preventive measures aimed to mitigate the spread of the virus. The threat of COVID-19 is particularly serious as there is no vaccine and no specific antiviral therapy. Further complications are introduced by shortages of personal protective equipment for healthcare workers who have direct contact with patients and effective testing to identify infected patients, raising the need for delaying some testing and therapies. Certain vulnerable segments of the general population have been identified (advanced age and certain comorbidities), which should heighten further their preventive efforts. Therefore, this guidance is intended to be operationalized depending on a facility’s specific needs and local disease prevalence. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.